Lincoln Pharmaceuticals Ltd (LINP)

Currency in INR
543.20
-1.20(-0.22%)
Delayed Data·
LINP Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
LINP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
541.60547.80
52 wk Range
500.00975.00
Key Statistics
Bid/Ask
541.55 / 543.30
Prev. Close
544.4
Open
545.7
Day's Range
541.6-547.8
52 wk Range
500-975
Volume
685
Average Volume (3m)
19.53K
1-Year Change
-17.98%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LINP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Lincoln Pharmaceuticals Ltd Company Profile

Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India. The company offers products in the areas of anticold, antibiotic, otolaryngology, pain management, gastro, anti-malarial, anti-fungal, corticosteroids and cosmo-derma, anti-diabetic, anti-hypertensive, gynecology, cardio and CNS, respiratory system, and dyslipidemic; and branded generics. It also exports its products to approximately 60 countries, including Europe, Canada, Latin and North America, Africa, the Asia Pacific, and South East Asia. The company was incorporated in 1979 and is based in Ahmedabad, India.

Employees
1687
Market
India

Compare LINP to Peers and Sector

Metrics to compare
LINP
Peers
Sector
Relationship
P/E Ratio
12.6x37.0x−0.5x
PEG Ratio
−1.060.130.00
Price/Book
1.6x3.3x2.6x
Price / LTM Sales
1.7x3.8x3.3x
Upside (Analyst Target)
-13.6%40.3%
Fair Value Upside
Unlock1.4%4.7%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 43.11%
Dividend Yield
0.33%
Industry Median 0.74%
Annualised payout
1.80
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Aug 12, 2025
EPS / Forecast
13.82 / --
Revenue / Forecast
1.54B / --
EPS Revisions
Last 90 days

LINP Income Statement

People Also Watch

2,040.00
GLEN
+0.53%
272.70
ADTB
+1.11%
8,580.00
APAR
-1.93%
1,868.50
ADVR
-0.54%

FAQ

What Stock Exchange Does Lincoln Pharmaceuticals Ltd Trade On?

Lincoln Pharmaceuticals Ltd is listed and trades on the Bombay Stock Exchange stock exchange.

What Is the Stock Symbol for Lincoln Pharmaceuticals Ltd?

The stock symbol for Lincoln Pharmaceuticals Ltd is "LINP."

What Is the Lincoln Pharmaceuticals Ltd Market Cap?

As of today, Lincoln Pharmaceuticals Ltd market cap is 10.86B.

What Is Lincoln Pharmaceuticals Ltd's Earnings Per Share (TTM)?

The Lincoln Pharmaceuticals Ltd EPS (TTM) is 43.11.

When Is the Next Lincoln Pharmaceuticals Ltd Earnings Date?

Lincoln Pharmaceuticals Ltd will release its next earnings report on 05 Nov 2025.

From a Technical Analysis Perspective, Is LINP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Lincoln Pharmaceuticals Ltd Stock Split?

Lincoln Pharmaceuticals Ltd has split 2 times.

How Many Employees Does Lincoln Pharmaceuticals Ltd Have?

Lincoln Pharmaceuticals Ltd has 1687 employees.

What is the current trading status of Lincoln Pharmaceuticals Ltd (LINP)?

As of 14 Aug 2025, Lincoln Pharmaceuticals Ltd (LINP) is trading at a price of 543.20, with a previous close of 544.40. The stock has fluctuated within a day range of 541.60 to 547.80, while its 52-week range spans from 500.00 to 975.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.